ClinicalTrials.gg
RecruitingNCT07637097VOCALE LBDUpdated Nov 12, 2026

VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia

An interventional study of VOCALE LBD: Virtual Online Communities for Aging Life Experiences: Lewy Body Dementia and Standard of Care Educational Materials in Lewy Bodies Disease, Depression Disorder and Caregiver Burden, sponsored by University of Washington. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by University of Washington · Not applicable, Interventional, and Treatment

How we know

Updated Nov 12, 2026Now RecruitingPrimary outcomes revised+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 228 studies in Caregiver Burden with a site in United States — 59 open to participants now, 71 under way, 1 of them phase 3. Caregiver Burden · United States.

Planned enrollment
36th of 208
220 · median 60
Started
2026
with 18 others
No phase
190 of 228
50 open now
Primary completion
2029-11
later than 64 of 70 live
Registered
216th of 228
by date
Lead sponsor
5 of 228
University of Washington

Among the 228 studies in Caregiver Burden with a site in United States, this one is the 36th largest by planned enrollment of the 208 interventional ones that give a count, is one of 19 that started in 2026, is one of 190 with no phase, reaches primary completion later than 64 of the 70 other live ones, and was the 216th registered.

Caregiver Burden

503 studies on the registry are indexed under Caregiver Burden; 166 are open to participants now.

Browse Caregiver Burden studies →

Open to participants now

59 of the 228 studies in Caregiver Burden with a site in United States are open now. Recruiting first, the newest first:

53 more — sign in →

All 59 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 90 Caregiver Burden studies recruiting now, 69 (77%) set no upper age limit and 7 (8%) stop at 75 or younger; 8 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 228 studies in Caregiver Burden with a site in United States, or all of them as a file.
02

Study summary

This study tests whether a tailored, fully asynchronous online group intervention (VOCALE LBD) reduces depression in family caregivers of people with Lewy Body Dementia (LBD), compared to standard educational materials. LBD is the second most common form of degenerative dementia and causes distinct challenges, including visual hallucinations, REM sleep disorder, and severe motor symptoms, that are not addressed by generic caregiver interventions. Depression rates in LBD caregivers reach 40-50%, double the rate seen in Alzheimer's disease caregivers, yet no rigorous digital interventions exist specifically for this population. VOCALE LBD is a text-based, low-bandwidth platform (Discourse) that brings groups of 10-15 caregivers together in an 8-week moderated online community. Weekly topics address LBD-specific challenges (sleep problems, hallucinations, self-care) and problem-solving skills using the ADAPT method. A pilot study (n=54) showed strong effects on depressive symptoms (Cohen's d=0.54 at 1-month follow-up), near-perfect engagement, and high participant satisfaction. This RCT (N=220) will test efficacy, examine mechanisms of action (self-efficacy and problem-solving), and explore analytics approaches for pragmatic monitoring, laying groundwork for future implementation in clinics and community organizations.

Read the detailed description

Over 1.4 million people in the U.S. are diagnosed with Lewy Body Dementia (LBD). Up to 80% receive care from family members, yet family caregivers of people with LBD experience depression at rates (40-50%) double those of Alzheimer's disease caregivers. LBD's distinct features - visual hallucinations, REM sleep behavior disorder, cognitive fluctuations, and Parkinsonian motor symptoms - create caregiving demands not addressed by existing dementia caregiver interventions. Current pharmacological treatments for LBD are largely experimental, leaving families to manage severe behavioral and motor symptoms without adequate support. INTERVENTION: VOCALE LBD (Virtual Online Communities for Aging Life Experiences - Lewy Body Dementia) is a fully asynchronous, text-based online group intervention delivered via the Discourse platform. The 8-week program includes icebreaker activities followed by LBD-specific weekly topics (self-care, sleep problems, hallucinations and delusions) and problem-solving training using the ADAPT method (Adopting a positive attitude, Defining the problem, brainstorming Alternatives, Predicting consequences, Trying the solution). Groups of 10-15 caregivers are moderated by a licensed nurse or social worker (RN/LCSW), who logs in daily and facilitates discussions. The platform requires no video conferencing and is accessible via any internet-connected device. Loaner devices and digital literacy training are provided for participants who need them. STUDY DESIGN: Two-arm, randomized controlled trial. Participants are randomized 1:1 to (a) VOCALE LBD or (b) Standard of Care (SOC: NIA psychoeducational materials, LBDA resource list, problem-solving handouts). Assessment time points: baseline, post-intervention (week 8), and 6-month follow-up. Exit interviews are conducted at the end of the intervention. AIMS: Aim 1 tests whether VOCALE LBD reduces depressive symptoms (CES-D) compared to SOC at week 8, with sustained effect at 6 months. Aim 2 examines mechanisms - whether self-efficacy and problem-solving mediate outcomes (2a quantitative mediation; 2b qualitative analysis). Aim 3 explores pragmatic monitoring using user engagement analytics, natural language processing, and LLM-assisted moderator support tools. RECRUITMENT: Nationwide recruitment through the Lewy Body Dementia Association (LBDA) via eblasts, social media, support groups, and print materials. Additional outreach via Alzheimer.gov and national LBD caregiver web resources.

03

Conditions studied

  • Lewy Bodies Disease
  • Depression Disorder
  • Caregiver Burden
  • Caregivers

Keywords

  • Lewy body disease
  • LBD
  • Family caregivers
  • Caregiver Depression
  • Online Intervention
  • Asynchronous
  • Digital Health
  • Peer Support
  • Problem-solving therapy
  • VOCALE
  • Telehealth
  • Dementia caregiver
  • ADAPT method
  • Discourse Platform
04

Who can participate

The criteria were revised on the registry on Nov 4, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Current family member or informal (unpaid) caregiver of a person with a confirmed diagnosis of Lewy Body Dementia (LBD) or LBD mixed pathology
  • Experiences depressive symptoms as defined by a score of 5 or higher on the Patient Health Questionnaire-9 (PHQ-9)
  • Able to read, write, and speak English
  • Has access to a device (computer, tablet, or smartphone) that can connect to the internet and be used for videoconferencing or phone calls, OR is interested in using a loaner device
  • Has an active email address OR is willing to create and use an email address prior to enrollment

Exclusion criteria

Exclusion Criteria:

  • Active suicidal ideation as indicated by endorsement of PHQ-9 Item 9 (thoughts that you would be better off dead, or thoughts of hurting yourself)
  • Paid or professional caregiver (must be unpaid family/informal caregiver)
  • Unable to read, write, or speak English
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
220 participants (estimated)

Study arms

  • Experimental
    VOCALE LBD

    Participants in this arm receive the VOCALE LBD intervention: an 8-week, fully asynchronous, text-based online group program delivered via the Discourse platform. Groups of 10-15 participants are facilitated by trained moderators who log in daily. Weekly discussion topics address LBD-specific caregiving challenges (sleep problems, hallucinations and delusions) and problem-solving skills training using the ADAPT method. Participants are asked to make a minimum of three posts each week (e.g., adding a post, replying to two other users).

    Behavioral: VOCALE LBD: Virtual Online Communities for Aging Life Experiences: Lewy Body Dementia

  • Active comparator
    Standard of Care

    NIA and LBDA psychoeducational materials on LBD and caregiving; LBDA resource list; problem-solving principles handout. Materials delivered via email.

    Other: Standard of Care Educational Materials

Interventions

  • BehavioralVOCALE LBD: Virtual Online Communities for Aging Life Experiences: Lewy Body Dementia

    The 8-week VOCALE LBD intervention is delivered asynchronously via the Discourse online platform. The weekly curriculum includes: Pre-intervention (Icebreakers, Self-introductions); Week 1 (Sleep Problems); Week 2 (Hallucinations and Delusions); Week 3 (ADAPT - Positive Attitude); Week 4 (ADAPT - Define the Problem); Week 5 (ADAPT - Alternative Solutions); Week 6 (ADAPT - Plan); Week 7 (ADAPT - Try); Week 8 (Reflection and Wrap Up).

    Also known as: VOCALE LBD, Virtual Online Community, Asynchronous Online Group Intervention

  • OtherStandard of Care Educational Materials

    NIA and LBDA psychoeducational materials on LBD and caregiving; LBDA resource list; problem-solving principles handout. Materials delivered via email or mail per participant preference.

06

What researchers measure

Primary outcomes

  1. Center for Epidemiologic Studies Depression Scale (CES-D)

    The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-report questionnaire that evaluates the frequency of depressive symptoms experienced in the past week (including depressed mood, feelings of guilt/worthlessness, helplessness, and physical symptoms). Total scores range from 0 to 60. Higher scores indicate greater severity of depressive symptoms (worse outcome).

    Time frame: Baseline (pre-randomization), Post-intervention (Week 8), 6-month follow-up

Secondary outcomes

  1. Short Zarit Caregiver Burden Interview (ZBI-12)

    The Short Zarit Caregiver Burden Interview (ZBI-12) is a 12-item self-report instrument that measures personal strain and role strain associated with caregiving. Total scores range from 0 to 48. Higher scores indicate greater caregiver burden (worse outcome).

    Time frame: Baseline, Week 8, 6-month follow-up

  2. UCLA Loneliness Scale (3-Item Short Form)

    The UCLA Loneliness Scale (3-Item Short Form) is a 3-item self-report survey assessing subjective feelings of loneliness and social isolation. Total scores range from 3 to 9. Higher scores indicate greater loneliness and social isolation (worse outcome).

    Time frame: Baseline, Week 8, 6-month follow-up

  3. Perceived Stress Scale (PSS-10)

    The Perceived Stress Scale (PSS-10) is a 10-item instrument measuring an individual's perception of stress and feelings of unpredictability, uncontrollability, and overload during the past month. Total scores range from 0 to 40. Higher scores indicate greater perceived stress (worse outcome).

    Time frame: Baseline, Week 8, 6-month follow-up

  4. Medical Outcomes Study Social Support Survey (MOS-SSS)

    The Medical Outcomes Study Social Support Survey (MOS-SSS) is a 19-item questionnaire evaluating multiple dimensions of social support (emotional/informational, tangible, affectionate, and positive social interaction). Raw total scores range from 19 to 95 (which can be transformed to an overall index score of 0 to 100). Higher scores indicate greater social support (better outcome).

    Time frame: Baseline, Week 5 (mid-intervention), Week 8, 6-month follow-up

Other outcomes

  1. Social Problem-Solving Inventory-Revised (SPSI-R Short Form)

    The Social Problem-Solving Inventory-Revised (SPSI-R:S) is a 25-item self-report instrument assessing cognitive and behavioral problem-solving orientations and skills across five subscales (Positive Problem Orientation, Negative Problem Orientation, Rational Problem Solving, Impulsivity/Carelessness Style, and Avoidance Style). Standardized total scores range from 0 to 20. Higher total scores indicate better social problem-solving skills (better outcome). Used as mechanistic measure.

    Time frame: Baseline, Week 5, Week 8, 6-month follow-up

  2. General Self-Efficacy Scale (GSE)

    The General Self-Efficacy Scale (GSE) is a 10-item self-report questionnaire assessing optimistic self-beliefs and confidence in coping with daily difficulties and novel situations. Total scores range from 10 to 40. Higher scores indicate greater general self-efficacy (better outcome).

    Time frame: Baseline, Week 5, Week 8, 6-month follow-up

  3. Caregiver Self-Efficacy Scale (CSES-8)

    The Caregiver Self-Efficacy Scale is an 8-item self-report questionnaire measuring caregiver confidence in managing caregiving demands, obtaining respite, and handling challenging behaviors. Total scores range from 0 to 100 (percent confidence). Higher scores indicate greater caregiver self-efficacy (better outcome).

    Time frame: Baseline, Week 5, Week 8, 6-month follow-up

  4. User Engagement Scale (UES)

    The User Engagement Scale (UES) is a 31-item self-report survey characterizing the depth and quality of participant interactions with the online discussion platform across four subdomains (focused attention, perceived usability, aesthetic appeal, and reward). Mean item scores range from 1 to 5. Higher scores indicate greater platform engagement (better outcome).

    Time frame: Week 8

  5. Benefits of Participating Scale

    The Benefits of Participating Scale is a 4-item questionnaire evaluating perceived personal benefit and satisfaction with program participation (rated on a 3-point scale: 1 = Not at all, 2 = Some, 3 = A great deal). Total scores range from 4 to 12. Higher scores indicate greater perceived benefit and study satisfaction (better outcome).

    Time frame: Week 8, 6-month follow-up

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data that underlie the results reported in publications (text, tables, figures, appendices) will be shared. Data will be made available 9 months following publication of the primary study results. Data will be deposited in an NIH-designated repository (e.g., NIMH Data Archive or ICPSR). Requests for data should include a data analysis plan and be submitted to the PI.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Beginning 9 months after publication of primary outcome results; available for 5 years.

Access criteria: Researchers who provide a methodologically sound data analysis plan. Proposals should be directed to zaslav@uw.edu. To gain access, data requestors will need to sign a data access agreement.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Nov 2029, 35 months later.

Of 285 non-industry interventional studies with no phase under Caregiver Burden, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's planned 35 months is above that.

Counting every sponsor, half of 294 studies reached it within 16 months; a quarter within 7 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2026
First posted
Jun 9, 2026
StartEst.
Dec 1, 2026
Primary completionEst.
Nov 30, 2029
CompletionEst.
Nov 30, 2030
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 4, 2026
Sites
University of Washington is now Recruiting
Nov 4, 2026
Eligibility
1 inclusion criterion added
What changed in the criteria
Inclusion criteria
  • AddedHas an active email address OR is willing to create and use an email address prior to enrollment
Nov 4, 2026
Primary outcomes
Revised in 2 updates
What changed on Nov 4, 2026
  • EditedDepressive Symptoms, Center for Epidemiologic Studies Depression Scale (CES-D)Time frame: Baseline (pre-randomization), Post-Intervention (Week 8), 6-Month Follow-Up → Baseline (pre-randomization), Post-intervention (Week 8), 6-month follow-up
What changed on Nov 12, 2026
  • DescriptionCenter for Epidemiologic Studies Depression Scale (CES-D): how it is measured was reworded
across 2 updates, Nov 4, 2026 – Nov 12, 2026
Secondary outcomes
Revised in 2 updates
What changed on Nov 4, 2026
  • EditedPerceived stressStress Scale (PSS-10)Time frame: Baseline, Week 8, 6-month Follow-up → Baseline, Week 8, 6-month follow-up
  • EditedSocial Support Medical Outcomes Study (MOS) ScaleTime frame: Baseline, Week 8, 6-month follow-up → Baseline, Week 5 (mid-intervention), Week 8, 6-month follow-up
  • EditedUCLA Loneliness ScaleTime frame: Baseline, Week 8, 6 month follow-up → Baseline, Week 8, 6-month follow-up
  • EditedHealthGeneral Self-Efficacy ScaleTime frame: Baseline, Week 4, Week 8, 6-month follow-up → Baseline, Week 5, Week 8, 6-month follow-up
  • AddedShort Zarit Caregiver Burden InterviewTime frame: Baseline, Week 8, 6-month follow-up
  • AddedSocial Problem Solving Inventory-Revised (SPSI-R)Time frame: Baseline, Week 5, Week 8, 6-month follow-up
  • AddedCaregiver Self-EfficacyTime frame: Baseline, Week 5, Week 8, 6-month follow-up
  • AddedUser Engagement Scale (UES)Time frame: Week 8
  • AddedBenefits of Participating ScaleTime frame: Week 8, 6-month follow-up
  • RemovedCaregiving BurdenTime frame: Baseline, Week 8, 6 month follow-up
  • RemovedPlatform EngagementTime frame: Post Intervention (week 8)
  • RemovedProblem SolvingTime frame: Baseline, Week 4, Week 8, 6-month followup
  • RemovedSustained Effect on Depression (CES-D)Time frame: 6-Month Follow-up
What changed on Nov 12, 2026
  • EditedShort Zarit Caregiver Burden Interview (ZBI-12)Time frame: Baseline, Week 8, 6-month follow-up
  • EditedSocial Support Medical Outcomes Study Social Support Survey (MOS-SSS) ScaleTime frame: Baseline, Week 5 (mid-intervention), Week 8, 6-month follow-up
  • AddedUCLA Loneliness Scale (3-Item Short Form)Time frame: Baseline, Week 8, 6-month follow-up
  • RemovedUCLA Loneliness ScaleTime frame: Baseline, Week 8, 6-month follow-up
  • RemovedSocial Problem Solving Inventory-Revised (SPSI-R)Time frame: Baseline, Week 5, Week 8, 6-month follow-up
  • RemovedGeneral Self-Efficacy ScaleTime frame: Baseline, Week 5, Week 8, 6-month follow-up
  • RemovedCaregiver Self-EfficacyTime frame: Baseline, Week 5, Week 8, 6-month follow-up
  • RemovedUser Engagement Scale (UES)Time frame: Week 8
  • RemovedBenefits of Participating ScaleTime frame: Week 8, 6-month follow-up
  • DescriptionPerceived Stress Scale (PSS-10): how it is measured was reworded
  • Addedother outcomeSocial Problem-Solving Inventory-Revised (SPSI-R Short Form)Time frame: Baseline, Week 5, Week 8, 6-month follow-up
  • Addedother outcomeGeneral Self-Efficacy Scale (GSE)Time frame: Baseline, Week 5, Week 8, 6-month follow-up
  • Addedother outcomeCaregiver Self-Efficacy Scale (CSES-8)Time frame: Baseline, Week 5, Week 8, 6-month follow-up
  • Addedother outcomeUser Engagement Scale (UES)Time frame: Week 8
  • Addedother outcomeBenefits of Participating ScaleTime frame: Week 8, 6-month follow-up
across 2 updates, Nov 4, 2026 – Nov 12, 2026
Contact
Study contact changed: added v•••@uw.edu · •••8329. See the current contact
Nov 4, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • University of Washington · Seattle, United StatesContact added v•••@uw.edu · •••8329Contact added (no phone or email listed)
Nov 4, 2026
Show all 2 updates
  1. Nov 12, 2026
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionCenter for Epidemiologic Studies Depression Scale (CES-D): how it is measured was reworded
    Secondary outcomes 2 edited, 6 added, 6 removed, 1 description edited
    What changed in the outcomes
    • EditedShort Zarit Caregiver Burden Interview (ZBI-12)Time frame: Baseline, Week 8, 6-month follow-up
    • EditedSocial Support Medical Outcomes Study Social Support Survey (MOS-SSS) ScaleTime frame: Baseline, Week 5 (mid-intervention), Week 8, 6-month follow-up
    • AddedUCLA Loneliness Scale (3-Item Short Form)Time frame: Baseline, Week 8, 6-month follow-up
    • RemovedUCLA Loneliness ScaleTime frame: Baseline, Week 8, 6-month follow-up
    • RemovedSocial Problem Solving Inventory-Revised (SPSI-R)Time frame: Baseline, Week 5, Week 8, 6-month follow-up
    • RemovedGeneral Self-Efficacy ScaleTime frame: Baseline, Week 5, Week 8, 6-month follow-up
    • RemovedCaregiver Self-EfficacyTime frame: Baseline, Week 5, Week 8, 6-month follow-up
    • RemovedUser Engagement Scale (UES)Time frame: Week 8
    • RemovedBenefits of Participating ScaleTime frame: Week 8, 6-month follow-up
    • DescriptionPerceived Stress Scale (PSS-10): how it is measured was reworded
    • Addedother outcomeSocial Problem-Solving Inventory-Revised (SPSI-R Short Form)Time frame: Baseline, Week 5, Week 8, 6-month follow-up
    • Addedother outcomeGeneral Self-Efficacy Scale (GSE)Time frame: Baseline, Week 5, Week 8, 6-month follow-up
    • Addedother outcomeCaregiver Self-Efficacy Scale (CSES-8)Time frame: Baseline, Week 5, Week 8, 6-month follow-up
    • Addedother outcomeUser Engagement Scale (UES)Time frame: Week 8
    • Addedother outcomeBenefits of Participating ScaleTime frame: Week 8, 6-month follow-up
    + 1 other change: verification date
  2. Nov 4, 2026
    Not yet recruiting→Recruiting
    University of Washington is now Recruiting
    Eligibility 1 inclusion criterion added
    What changed in the criteria
    Inclusion criteria
    • AddedHas an active email address OR is willing to create and use an email address prior to enrollment
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedDepressive Symptoms, Center for Epidemiologic Studies Depression Scale (CES-D)Time frame: Baseline (pre-randomization), Post-Intervention (Week 8), 6-Month Follow-Up → Baseline (pre-randomization), Post-intervention (Week 8), 6-month follow-up
    Secondary outcomes 4 edited, 5 added, 4 removed
    What changed in the outcomes
    • EditedPerceived stressStress Scale (PSS-10)Time frame: Baseline, Week 8, 6-month Follow-up → Baseline, Week 8, 6-month follow-up
    • EditedSocial Support Medical Outcomes Study (MOS) ScaleTime frame: Baseline, Week 8, 6-month follow-up → Baseline, Week 5 (mid-intervention), Week 8, 6-month follow-up
    • EditedUCLA Loneliness ScaleTime frame: Baseline, Week 8, 6 month follow-up → Baseline, Week 8, 6-month follow-up
    • EditedHealthGeneral Self-Efficacy ScaleTime frame: Baseline, Week 4, Week 8, 6-month follow-up → Baseline, Week 5, Week 8, 6-month follow-up
    • AddedShort Zarit Caregiver Burden InterviewTime frame: Baseline, Week 8, 6-month follow-up
    • AddedSocial Problem Solving Inventory-Revised (SPSI-R)Time frame: Baseline, Week 5, Week 8, 6-month follow-up
    • AddedCaregiver Self-EfficacyTime frame: Baseline, Week 5, Week 8, 6-month follow-up
    • AddedUser Engagement Scale (UES)Time frame: Week 8
    • AddedBenefits of Participating ScaleTime frame: Week 8, 6-month follow-up
    • RemovedCaregiving BurdenTime frame: Baseline, Week 8, 6 month follow-up
    • RemovedPlatform EngagementTime frame: Post Intervention (week 8)
    • RemovedProblem SolvingTime frame: Baseline, Week 4, Week 8, 6-month followup
    • RemovedSustained Effect on Depression (CES-D)Time frame: 6-Month Follow-up
    Contact Study contact changed: added v•••@uw.edu · •••8329. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • University of Washington · Seattle, United StatesContact added v•••@uw.edu · •••8329Contact added (no phone or email listed)
    + 3 other changes: identifiers, verification date and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07637097
Responsible party
Oleg Zaslavsky (Associate Professor, University of Washington School of Nursing, University of Washington) — Principal investigator
First posted
Jun 9, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Nov 30, 2029 (estimated)
Completion
Nov 30, 2030 (estimated)
Last update
Nov 12, 2026

Study contacts

Aimy Paulsen, MPH
Contact
vocale-lbd@uw.edu
(253) 693-8329
Oleg Zaslavsky, PhD, RN
Contact
zaslav@uw.edu
(206) 849-3301
Oleg Zaslavsky, PhD, RN
principal investigator · University of Washington, School of Nursing

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion